Here’s what you need to know about Plasma therapy for CORONA virus Kumar Jeetendra | April 17, 2020 As of late, specialists have discovered that the body can recuperate itself. Platelet-rich plasma treatment is a type of regenerative medication that can bridle those capacities and intensify the regular development factors your body uses to recuperate tissue. What is plasma and what are platelets? Plasma is the fluid part of entire blood. It is …
Wockhardt’s epic anti-microbial WCK6777 gets quick track status from USFDA Kumar Jeetendra | April 20, 2020 Wockhardt has gotten the Qualified Infectious Disease Product (QIDP) assignment for WCK 6777 from the United States Food and Drug Administration (USFDA). WCK 6777 is a once-a-day blend anti-toxin dependent on Wockhardt’s NCE Zidebactam, which confers WCK 6777 novel system of lactam enhancer. Being a once-a-day tranquilize, WCK 6777 would be the principal ever anti-microbial …
Sanofi and Regeneron downsize Kevzara’s COVID-19 test Kumar Jeetendra | April 28, 2020 Accomplices Sanofi (Euronext: SAN) and Regeneron Pharmaceuticals (Nasdaq: REGN) have reported that – following a survey by the Independent Data Monitoring Committee (IDMC) – its examination deal with Kevzara (sarilumab) in COVID-19 will be downsized. The organizations have declared the starter results from the Phase II part of a continuous Phase II/III preliminary assessing the …
Chikungunya: The silent vector borne co-infection in Monsoon season Kumar Jeetendra | September 20, 2020 The prevalence of fever and joint pain is so common of symptoms that it overlaps with almost any prevalent disease in the tropics and hence for the better part of the virulent pathway of CHIK virus in the body, the patients remain asymptomatic to the detection of Chikungunya, thereby making it more life-threatening and requiring …
